Once-weekly semaglutide for obesity or overweight: A systematic review and meta-analysis

Diabetes Obes Metab. 2022 Apr;24(4):722-726. doi: 10.1111/dom.14612. Epub 2021 Dec 20.
No abstract available

Keywords: meta-analysis; obesity; overweight; randomized controlled trials; semaglutide.

Publication types

  • Letter
  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptides / adverse effects
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Obesity / drug therapy
  • Overweight* / complications
  • Overweight* / drug therapy

Substances

  • Hypoglycemic Agents
  • semaglutide
  • Glucagon-Like Peptides